Global Human Erythropoin Injection Supply, Demand and Key Producers, 2023-2029

June 2023 | 105 pages | ID: G1AB0A8E1D50EN
GlobalInfoResearch

Abstracts

The global Human Erythropoin Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The human erythropoietin injection is an active glycoprotein secreted by the kidney, which acts on the erythroid hematopoietic progenitor cells in the bone marrow to promote their proliferation and differentiation.

This report studies the global Human Erythropoin Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Erythropoin Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Erythropoin Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Human Erythropoin Injection total production and demand, 2018-2029, (K Units)

Global Human Erythropoin Injection total production value, 2018-2029, (USD Million)

Global Human Erythropoin Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Human Erythropoin Injection consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Human Erythropoin Injection domestic production, consumption, key domestic manufacturers and share

Global Human Erythropoin Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Human Erythropoin Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Human Erythropoin Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Human Erythropoin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Ortho Biotech, Roche, Harbin Pharmaceutical Group Bio-vaccine, 3SBio Group, Kexing Biopharm, North China Pharmaceutical Jintan Biotechnology, Kirin Kunpeng Bio-pharmaceutical and Chemo Wanbang Biopharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Erythropoin Injection market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Erythropoin Injection Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Human Erythropoin Injection Market, Segmentation by Type

• Colorless
• Clarify
• Slightly Milky

Global Human Erythropoin Injection Market, Segmentation by Application

• Anemia Due to Renal Insufficiency
• Anemia Induced by Chemotherapy in Non-myeloid Malignancies
• Others

Companies Profiled:

• Amgen
• Ortho Biotech
• Roche
• Harbin Pharmaceutical Group Bio-vaccine
• 3SBio Group
• Kexing Biopharm
• North China Pharmaceutical Jintan Biotechnology
• Kirin Kunpeng Bio-pharmaceutical
• Chemo Wanbang Biopharma
• Si Huan Sheng Wu

Key Questions Answered

1. How big is the global Human Erythropoin Injection market?

2. What is the demand of the global Human Erythropoin Injection market?

3. What is the year over year growth of the global Human Erythropoin Injection market?

4. What is the production and production value of the global Human Erythropoin Injection market?

5. Who are the key producers in the global Human Erythropoin Injection market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Human Erythropoin Injection Introduction
1.2 World Human Erythropoin Injection Supply & Forecast
  1.2.1 World Human Erythropoin Injection Production Value (2018 & 2022 & 2029)
  1.2.2 World Human Erythropoin Injection Production (2018-2029)
  1.2.3 World Human Erythropoin Injection Pricing Trends (2018-2029)
1.3 World Human Erythropoin Injection Production by Region (Based on Production Site)
  1.3.1 World Human Erythropoin Injection Production Value by Region (2018-2029)
  1.3.2 World Human Erythropoin Injection Production by Region (2018-2029)
  1.3.3 World Human Erythropoin Injection Average Price by Region (2018-2029)
  1.3.4 North America Human Erythropoin Injection Production (2018-2029)
  1.3.5 Europe Human Erythropoin Injection Production (2018-2029)
  1.3.6 China Human Erythropoin Injection Production (2018-2029)
  1.3.7 Japan Human Erythropoin Injection Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Human Erythropoin Injection Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Human Erythropoin Injection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Human Erythropoin Injection Demand (2018-2029)
2.2 World Human Erythropoin Injection Consumption by Region
  2.2.1 World Human Erythropoin Injection Consumption by Region (2018-2023)
  2.2.2 World Human Erythropoin Injection Consumption Forecast by Region (2024-2029)
2.3 United States Human Erythropoin Injection Consumption (2018-2029)
2.4 China Human Erythropoin Injection Consumption (2018-2029)
2.5 Europe Human Erythropoin Injection Consumption (2018-2029)
2.6 Japan Human Erythropoin Injection Consumption (2018-2029)
2.7 South Korea Human Erythropoin Injection Consumption (2018-2029)
2.8 ASEAN Human Erythropoin Injection Consumption (2018-2029)
2.9 India Human Erythropoin Injection Consumption (2018-2029)

3 WORLD HUMAN ERYTHROPOIN INJECTION MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Human Erythropoin Injection Production Value by Manufacturer (2018-2023)
3.2 World Human Erythropoin Injection Production by Manufacturer (2018-2023)
3.3 World Human Erythropoin Injection Average Price by Manufacturer (2018-2023)
3.4 Human Erythropoin Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Human Erythropoin Injection Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Human Erythropoin Injection in 2022
  3.5.3 Global Concentration Ratios (CR8) for Human Erythropoin Injection in 2022
3.6 Human Erythropoin Injection Market: Overall Company Footprint Analysis
  3.6.1 Human Erythropoin Injection Market: Region Footprint
  3.6.2 Human Erythropoin Injection Market: Company Product Type Footprint
  3.6.3 Human Erythropoin Injection Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Human Erythropoin Injection Production Value Comparison
  4.1.1 United States VS China: Human Erythropoin Injection Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Human Erythropoin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Erythropoin Injection Production Comparison
  4.2.1 United States VS China: Human Erythropoin Injection Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Human Erythropoin Injection Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Erythropoin Injection Consumption Comparison
  4.3.1 United States VS China: Human Erythropoin Injection Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Human Erythropoin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Erythropoin Injection Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Human Erythropoin Injection Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Human Erythropoin Injection Production (2018-2023)
4.5 China Based Human Erythropoin Injection Manufacturers and Market Share
  4.5.1 China Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Human Erythropoin Injection Production Value (2018-2023)
  4.5.3 China Based Manufacturers Human Erythropoin Injection Production (2018-2023)
4.6 Rest of World Based Human Erythropoin Injection Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Human Erythropoin Injection Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Human Erythropoin Injection Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Human Erythropoin Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Colorless
  5.2.2 Clarify
  5.2.3 Slightly Milky
5.3 Market Segment by Type
  5.3.1 World Human Erythropoin Injection Production by Type (2018-2029)
  5.3.2 World Human Erythropoin Injection Production Value by Type (2018-2029)
  5.3.3 World Human Erythropoin Injection Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Human Erythropoin Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Anemia Due to Renal Insufficiency
  6.2.2 Anemia Induced by Chemotherapy in Non-myeloid Malignancies
  6.2.3 Others
6.3 Market Segment by Application
  6.3.1 World Human Erythropoin Injection Production by Application (2018-2029)
  6.3.2 World Human Erythropoin Injection Production Value by Application (2018-2029)
  6.3.3 World Human Erythropoin Injection Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Amgen
  7.1.1 Amgen Details
  7.1.2 Amgen Major Business
  7.1.3 Amgen Human Erythropoin Injection Product and Services
  7.1.4 Amgen Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Amgen Recent Developments/Updates
  7.1.6 Amgen Competitive Strengths & Weaknesses
7.2 Ortho Biotech
  7.2.1 Ortho Biotech Details
  7.2.2 Ortho Biotech Major Business
  7.2.3 Ortho Biotech Human Erythropoin Injection Product and Services
  7.2.4 Ortho Biotech Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Ortho Biotech Recent Developments/Updates
  7.2.6 Ortho Biotech Competitive Strengths & Weaknesses
7.3 Roche
  7.3.1 Roche Details
  7.3.2 Roche Major Business
  7.3.3 Roche Human Erythropoin Injection Product and Services
  7.3.4 Roche Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Roche Recent Developments/Updates
  7.3.6 Roche Competitive Strengths & Weaknesses
7.4 Harbin Pharmaceutical Group Bio-vaccine
  7.4.1 Harbin Pharmaceutical Group Bio-vaccine Details
  7.4.2 Harbin Pharmaceutical Group Bio-vaccine Major Business
  7.4.3 Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Product and Services
  7.4.4 Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
  7.4.6 Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
7.5 3SBio Group
  7.5.1 3SBio Group Details
  7.5.2 3SBio Group Major Business
  7.5.3 3SBio Group Human Erythropoin Injection Product and Services
  7.5.4 3SBio Group Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 3SBio Group Recent Developments/Updates
  7.5.6 3SBio Group Competitive Strengths & Weaknesses
7.6 Kexing Biopharm
  7.6.1 Kexing Biopharm Details
  7.6.2 Kexing Biopharm Major Business
  7.6.3 Kexing Biopharm Human Erythropoin Injection Product and Services
  7.6.4 Kexing Biopharm Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Kexing Biopharm Recent Developments/Updates
  7.6.6 Kexing Biopharm Competitive Strengths & Weaknesses
7.7 North China Pharmaceutical Jintan Biotechnology
  7.7.1 North China Pharmaceutical Jintan Biotechnology Details
  7.7.2 North China Pharmaceutical Jintan Biotechnology Major Business
  7.7.3 North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Product and Services
  7.7.4 North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 North China Pharmaceutical Jintan Biotechnology Recent Developments/Updates
  7.7.6 North China Pharmaceutical Jintan Biotechnology Competitive Strengths & Weaknesses
7.8 Kirin Kunpeng Bio-pharmaceutical
  7.8.1 Kirin Kunpeng Bio-pharmaceutical Details
  7.8.2 Kirin Kunpeng Bio-pharmaceutical Major Business
  7.8.3 Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Product and Services
  7.8.4 Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Kirin Kunpeng Bio-pharmaceutical Recent Developments/Updates
  7.8.6 Kirin Kunpeng Bio-pharmaceutical Competitive Strengths & Weaknesses
7.9 Chemo Wanbang Biopharma
  7.9.1 Chemo Wanbang Biopharma Details
  7.9.2 Chemo Wanbang Biopharma Major Business
  7.9.3 Chemo Wanbang Biopharma Human Erythropoin Injection Product and Services
  7.9.4 Chemo Wanbang Biopharma Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Chemo Wanbang Biopharma Recent Developments/Updates
  7.9.6 Chemo Wanbang Biopharma Competitive Strengths & Weaknesses
7.10 Si Huan Sheng Wu
  7.10.1 Si Huan Sheng Wu Details
  7.10.2 Si Huan Sheng Wu Major Business
  7.10.3 Si Huan Sheng Wu Human Erythropoin Injection Product and Services
  7.10.4 Si Huan Sheng Wu Human Erythropoin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Si Huan Sheng Wu Recent Developments/Updates
  7.10.6 Si Huan Sheng Wu Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Human Erythropoin Injection Industry Chain
8.2 Human Erythropoin Injection Upstream Analysis
  8.2.1 Human Erythropoin Injection Core Raw Materials
  8.2.2 Main Manufacturers of Human Erythropoin Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Erythropoin Injection Production Mode
8.6 Human Erythropoin Injection Procurement Model
8.7 Human Erythropoin Injection Industry Sales Model and Sales Channels
  8.7.1 Human Erythropoin Injection Sales Model
  8.7.2 Human Erythropoin Injection Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Human Erythropoin Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Erythropoin Injection Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Erythropoin Injection Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Erythropoin Injection Production Value Market Share by Region (2018-2023)
Table 5. World Human Erythropoin Injection Production Value Market Share by Region (2024-2029)
Table 6. World Human Erythropoin Injection Production by Region (2018-2023) & (K Units)
Table 7. World Human Erythropoin Injection Production by Region (2024-2029) & (K Units)
Table 8. World Human Erythropoin Injection Production Market Share by Region (2018-2023)
Table 9. World Human Erythropoin Injection Production Market Share by Region (2024-2029)
Table 10. World Human Erythropoin Injection Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Erythropoin Injection Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Erythropoin Injection Major Market Trends
Table 13. World Human Erythropoin Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Erythropoin Injection Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Erythropoin Injection Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Erythropoin Injection Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Erythropoin Injection Producers in 2022
Table 18. World Human Erythropoin Injection Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Erythropoin Injection Producers in 2022
Table 20. World Human Erythropoin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Erythropoin Injection Company Evaluation Quadrant
Table 22. World Human Erythropoin Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Erythropoin Injection Production Site of Key Manufacturer
Table 24. Human Erythropoin Injection Market: Company Product Type Footprint
Table 25. Human Erythropoin Injection Market: Company Product Application Footprint
Table 26. Human Erythropoin Injection Competitive Factors
Table 27. Human Erythropoin Injection New Entrant and Capacity Expansion Plans
Table 28. Human Erythropoin Injection Mergers & Acquisitions Activity
Table 29. United States VS China Human Erythropoin Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Erythropoin Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Erythropoin Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Erythropoin Injection Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Erythropoin Injection Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Erythropoin Injection Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Erythropoin Injection Production Market Share (2018-2023)
Table 37. China Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Erythropoin Injection Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Erythropoin Injection Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Erythropoin Injection Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Erythropoin Injection Production Market Share (2018-2023)
Table 42. Rest of World Based Human Erythropoin Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Erythropoin Injection Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Erythropoin Injection Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Erythropoin Injection Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Erythropoin Injection Production Market Share (2018-2023)
Table 47. World Human Erythropoin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Erythropoin Injection Production by Type (2018-2023) & (K Units)
Table 49. World Human Erythropoin Injection Production by Type (2024-2029) & (K Units)
Table 50. World Human Erythropoin Injection Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Erythropoin Injection Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Erythropoin Injection Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Erythropoin Injection Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Erythropoin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Erythropoin Injection Production by Application (2018-2023) & (K Units)
Table 56. World Human Erythropoin Injection Production by Application (2024-2029) & (K Units)
Table 57. World Human Erythropoin Injection Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Erythropoin Injection Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Erythropoin Injection Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Erythropoin Injection Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Amgen Basic Information, Manufacturing Base and Competitors
Table 62. Amgen Major Business
Table 63. Amgen Human Erythropoin Injection Product and Services
Table 64. Amgen Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amgen Recent Developments/Updates
Table 66. Amgen Competitive Strengths & Weaknesses
Table 67. Ortho Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Ortho Biotech Major Business
Table 69. Ortho Biotech Human Erythropoin Injection Product and Services
Table 70. Ortho Biotech Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ortho Biotech Recent Developments/Updates
Table 72. Ortho Biotech Competitive Strengths & Weaknesses
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Human Erythropoin Injection Product and Services
Table 76. Roche Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Roche Recent Developments/Updates
Table 78. Roche Competitive Strengths & Weaknesses
Table 79. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Manufacturing Base and Competitors
Table 80. Harbin Pharmaceutical Group Bio-vaccine Major Business
Table 81. Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Product and Services
Table 82. Harbin Pharmaceutical Group Bio-vaccine Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates
Table 84. Harbin Pharmaceutical Group Bio-vaccine Competitive Strengths & Weaknesses
Table 85. 3SBio Group Basic Information, Manufacturing Base and Competitors
Table 86. 3SBio Group Major Business
Table 87. 3SBio Group Human Erythropoin Injection Product and Services
Table 88. 3SBio Group Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. 3SBio Group Recent Developments/Updates
Table 90. 3SBio Group Competitive Strengths & Weaknesses
Table 91. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
Table 92. Kexing Biopharm Major Business
Table 93. Kexing Biopharm Human Erythropoin Injection Product and Services
Table 94. Kexing Biopharm Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Kexing Biopharm Recent Developments/Updates
Table 96. Kexing Biopharm Competitive Strengths & Weaknesses
Table 97. North China Pharmaceutical Jintan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. North China Pharmaceutical Jintan Biotechnology Major Business
Table 99. North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Product and Services
Table 100. North China Pharmaceutical Jintan Biotechnology Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. North China Pharmaceutical Jintan Biotechnology Recent Developments/Updates
Table 102. North China Pharmaceutical Jintan Biotechnology Competitive Strengths & Weaknesses
Table 103. Kirin Kunpeng Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 104. Kirin Kunpeng Bio-pharmaceutical Major Business
Table 105. Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Product and Services
Table 106. Kirin Kunpeng Bio-pharmaceutical Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Kirin Kunpeng Bio-pharmaceutical Recent Developments/Updates
Table 108. Kirin Kunpeng Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 109. Chemo Wanbang Biopharma Basic Information, Manufacturing Base and Competitors
Table 110. Chemo Wanbang Biopharma Major Business
Table 111. Chemo Wanbang Biopharma Human Erythropoin Injection Product and Services
Table 112. Chemo Wanbang Biopharma Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Chemo Wanbang Biopharma Recent Developments/Updates
Table 114. Si Huan Sheng Wu Basic Information, Manufacturing Base and Competitors
Table 115. Si Huan Sheng Wu Major Business
Table 116. Si Huan Sheng Wu Human Erythropoin Injection Product and Services
Table 117. Si Huan Sheng Wu Human Erythropoin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Human Erythropoin Injection Upstream (Raw Materials)
Table 119. Human Erythropoin Injection Typical Customers
Table 120. Human Erythropoin Injection Typical Distributors

List Of Figures

LIST OF FIGURES

Figure 1. Human Erythropoin Injection Picture
Figure 2. World Human Erythropoin Injection Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Erythropoin Injection Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Erythropoin Injection Production (2018-2029) & (K Units)
Figure 5. World Human Erythropoin Injection Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Erythropoin Injection Production Value Market Share by Region (2018-2029)
Figure 7. World Human Erythropoin Injection Production Market Share by Region (2018-2029)
Figure 8. North America Human Erythropoin Injection Production (2018-2029) & (K Units)
Figure 9. Europe Human Erythropoin Injection Production (2018-2029) & (K Units)
Figure 10. China Human Erythropoin Injection Production (2018-2029) & (K Units)
Figure 11. Japan Human Erythropoin Injection Production (2018-2029) & (K Units)
Figure 12. Human Erythropoin Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 15. World Human Erythropoin Injection Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 17. China Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 22. India Human Erythropoin Injection Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Erythropoin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Erythropoin Injection Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Erythropoin Injection Markets in 2022
Figure 26. United States VS China: Human Erythropoin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Erythropoin Injection Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Erythropoin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Erythropoin Injection Production Market Share 2022
Figure 30. China Based Manufacturers Human Erythropoin Injection Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Erythropoin Injection Production Market Share 2022
Figure 32. World Human Erythropoin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Erythropoin Injection Production Value Market Share by Type in 2022
Figure 34. Colorless
Figure 35. Clarify
Figure 36. Slightly Milky
Figure 37. World Human Erythropoin Injection Production Market Share by Type (2018-2029)
Figure 38. World Human Erythropoin Injection Production Value Market Share by Type (2018-2029)
Figure 39. World Human Erythropoin Injection Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Human Erythropoin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Human Erythropoin Injection Production Value Market Share by Application in 2022
Figure 42. Anemia Due to Renal Insufficiency
Figure 43. Anemia Induced by Chemotherapy in Non-myeloid Malignancies
Figure 44. Others
Figure 45. World Human Erythropoin Injection Production Market Share by Application (2018-2029)
Figure 46. World Human Erythropoin Injection Production Value Market Share by Application (2018-2029)
Figure 47. World Human Erythropoin Injection Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Human Erythropoin Injection Industry Chain
Figure 49. Human Erythropoin Injection Procurement Model
Figure 50. Human Erythropoin Injection Sales Model
Figure 51. Human Erythropoin Injection Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source